Novartis

At the beginning of 2023, Dr. Roni (Aharon) Gal, one of the best-known and longest-serving analysts in biopharmaceuticals, surprised the market when he announced his career change. Gall, who was working as a senior…

TBE/iStock Editorial via Getty Images Novartis (NYSE:NVS) shareholders have voted for a 100% spinout of the company's generic drug and biosimilars unit Sandoz, with shares of the new company to be listed on the SIX Swiss Exchange.…

© Reuters. FILE PHOTO: A sign marks the Novartis Institutes for BioMedical Research facility in Cambridge, Massachusetts, U.S., June 16, 2021. REUTERS/Brian Snyder/File Photo By Patrick Wingrove (Reuters) - Swiss drugmaker Novartis…